FrancophonIA/ELRC3.0 huggingface dataset:
English: Symptomatic hypotension, especially after the first dose of Kinzalmono, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, or vomiting.
Danish: Specielt efter den første dosis af Kinzalmono kan der forekomme symptomatisk hypotension hos patienter, som har for lavt volumen i blodbanen eller natriummangel på grund af kraftig diuretisk behandling, saltfattig diæt, diarré eller opkastning.
English: Kinzalmono may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Kinzalmono.
Danish: Kinzalmono kan også ordineres i kombination med diuretika (vanddrivende medicin) såsom hydrochlorthiazid, der har vist sig at øge den blodtryksnedsættende virkning af Kinzalmono.
English: For treatment of high blood pressure, the usual dose of Kinzalmono for most patients is one 40 mg tablet once a day to control blood pressure over the 24-hour period.
Danish: Til behandling af forhøjet blodtryk er den normale dosering af Kinzalmono til kontrol af blodtrykket i 24 timer er én tablet á 40 mg én gang daglig.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Unit dose blister (28 x 1 tablets pack)
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP Unit dose-blister (28 x 1 tablet) og andre blisterkort bortset fra 7 styk
English: You should store your medicine in the original package in order to protect the tablets from moisture.
Danish: Du skal opbevare Kinzalmono i den originale yderpakning for at beskytte tabletterne mod fugt.
English: Kinzalmono is contraindicated in patients with severe hepatic impairment (see section 4.3).
Danish: Kinzalmono er kontraindiceret hos patienter med svært nedsat leverfunktion (se pkt.
English: Telmisartan should be kept in the sealed blister due to the hygroscopic property of the tablets.
Danish: 6.6 Regler for bortskaffelse og anden håndtering Telmisartan skal opbevares i den forseglede blister på grund af tabletternes hygroskopiske egenskaber.
English: Kinzalmono should be used only with caution in patients with mild to moderate hepatic impairment.
Danish: Der bør udvises forsigtighed, når Kinzalmono bruges til patienter med let til moderat nedsat leverfunktion.
English: • If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Kinzalmono” and “Warnings and precautions”).
Danish: • Hvis du samtidig tager en ACE-hæmmer eller aliskiren (se også information under overskriften
English: The overall incidence of adverse reactions reported with telmisartan (was usually comparable to placebo (41.4 % vs 43.9 %) in controlled trials in patients treated for hypertension.
Danish: I kontrollerede studier med hypertensionspatienter var den samlede forekomst af bivirkninger ved brug af telmisartan, sædvanligvis sammenlignelig med placebo (41,4% vs. 43,9%).
English: Kinzalmono 20 mg tablets 3 years
Danish: Kinzalmono 20 mg tabletter 3 år.
English: INFORMATION IN BRAILLE Kinzalmono 40 mg
Danish: INFORMATION I BRAILLESKRIFT Kinzalmono 40 mg
English: Kinzalmono is available in blister packs containing 14, 28, 56 or 98 tablets.
Danish: Kinzalmono er pakket i blisterpakninger med 14, 28, 56, eller 98 tabletter.
English: Kinzalmono is available in blister packs containing 14, 28, 56 or 98 tablets, or unit dose blister packs containing 28 x 1 tablets.
Danish: Kinzalmono er pakket i blisterpakninger med 14, 28, 56, eller 98 tabletter eller enkeltdosisblisterpakning indeholdende 28 x 1 tabletter.
English: The effect of Kinzalmono may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen) or corticosteroids.
Danish: Den blodtrykssænkende virkning med Kinzalmono kan blive mindre, hvis du samtidig tager medicin mod gigt og lette smerter (non-steroid antiinflammatorisk medicin (NSAID) såsom acetylsalicylsyre eller ibuprofen) eller kortikosteroider.
English: INFORMATION IN BRAILLE Kinzalmono 80 mg
Danish: INFORMATION I BRAILLESKRIFT Kinzalmono 80 mg
English: You should consult with your doctor if you need to adjust the dose of your other medicine while taking Kinzalmono.
Danish: Du skal derfor tale med din læge om eventuelt at få ændret doseringen af din medicin.
English: INFORMATION IN BRAILLE Kinzalmono 20 mg
Danish: INFORMATION I BRAILLESKRIFT Kinzalmono 20 mg
English: Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded.
Danish: Ud fra de epidemiologiske data kan man ikke konkludere, at behandling med ACE-hæmmere i første trimester medfører en risiko for teratogenicitet.
English: Kinzalmono is not to be given to patients with cholestasis, biliary obstructive disorders or severe hepatic impairment (see section 4.3) since telmisartan is mostly eliminated with the bile.
Danish: Kinzalmono må ikke gives til patienter med kolestase, obstruktive galdelidelser eller svært nedsat leverfunktion (se pkt.
English: Kinzalmono is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Danish: Hvis Kinzalmono tages mere end 3 måneder henne i graviditeten, kan det forårsage alvorlige fosterskader (se afsnit Graviditet).
English: • Diuretics ('water tablets'), especially if taken in high doses together with Kinzalmono, may lead to excessive loss of body water and low blood pressure (hypotension).
Danish: • Vanddrivende medicin i høje doser kan føre til overdrevent tab af kropsvæske og for lavt blodtryk
English: Kinzalmono 40 mg tablets
Danish: Kinzalmono 40 mg tabletter
English: Children and adolescents The use of Kinzalmono in children and adolescents up to the age of 18 years is not recommended.
Danish: Børn og unge Børn og unge under 18 år bør ikke behandles med Kinzalmono.
English: What Kinzalmono looks like and contents of the pack Kinzalmono 20 mg tablets are white, round and engraved with the code number '50H' on one side and the company logo on the other side.
Danish: Udseende og pakningsstørrelser Kinzalmono 20 mg tabletter er hvide runde tabletter, hvorpå firmaets logo og koden 50H er præget.
English: Kinzalmono is also used to reduce cardiovascular events (i.e. heart attack or stroke) in adults who are at risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke or have high risk diabetes.
Danish: Kinzalmono bruges også til at nedsætte risikoen for hjerte-kar-hændelser og blodprop i hjernen hos voksne, som har en forøget risiko.
English: • Renal artery stenosis (narrowing of the blood vessels to one or both kidneys).
Danish: • Nedsat blodtilstrømning til en eller begge nyrer /nyrearteriestenose)
English: Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory response which can lead to death), increase in certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat (tachycardia), dry mouth, upset stomach, taste disturbance (dysgeusia), abnormal liver function (Japanese patients are more likely to experience this side effect), rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash, joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
Danish: Sepsis* (ofte kaldet “blodforgiftning”, en alvorlig infektion med en betændelsesreaktion i hele kroppen, som kan føre til døden), øget antal hvide blodlegemer (eosinofili), for få blodplader (trombocytopeni), alvorlige allergiske reaktioner (anafylaktisk reaktion), overfølsomhedsreaktioner (såsom udslæt, kløe, vejrtrækningsbesvær, hvæsende åndedræt, hævelser i ansigtet og lavt blodtryk), lave blodsukkerniveauer (hos sukkersygepatienter), nervøsitet, søvnighed, nedsat syn, hurtig hjerterytme (puls), mundtørhed, maveuro, smagsforstyrrelser, unormal leverfunktion (japanske patienter har større sandsynlighed for at opleve denne bivirkning), hurtigt indsættende hævelse af hals og slimhinder (angioødem), som kan være dødelig, eksem, hudrødme, nældefeber, alvorligt medicinudløst udslæt, ledsmerter, smerter i arme og ben, senesmerter, influenzalignende symptomer, nedsat hæmoglobin samt forhøjet urinsyre, forhøjede leverenzymer eller forhøjet kreatinkinase i blodet.
English: Kinzalmono 80 mg tablets
Danish: Kinzalmono 80 mg tabletter
English: In preclinical studies, no effects of Kinzalmono on male and female fertility were observed.
Danish: I prækliniske studier blev der ikke påvist nedsat fertilitet hos hunner eller hanner ved brug af telmisartan.
English: Kinzalmono 20 mg tablets
Danish: Kinzalmono 20 mg tabletter
English: Kinzalmono 20 mg tablets EU/1/98/091/009 (14 tablets) EU/1/98/091/010 (28 tablets) EU/1/98/091/011 (56 tablets) EU/1/98/091/012 (98 tablets)
Danish: Kinzalmono 20 mg tabletter EU/1/98/091/009 (14 tabletter) EU/1/98/091/010 (28 tabletter) EU/1/98/091/011 (56 tabletter) EU/1/98/091/012 (98 tabletter)
English: How to take Kinzalmono
Danish: Sådan skal du tage Kinzalmono
English: What Kinzalmono is and what it is used for What you need to know before you take Kinzalmono How to take Kinzalmono
Danish: Det skal du vide, før du begynder at tage Kinzalmono Sådan skal du tage Kinzalmono Bivirkninger
English: NAME OF THE MEDICINAL PRODUCT Kinzalmono 40 mg tablets telmisartan
Danish: LÆGEMIDLETS NAVN Kinzalmono 40 mg tabletter Telmisartan
English: If concomitant use is indicated because of documented hypokalaemia they should be used with caution and with frequent monitoring of serum potassium.
Danish: Der bør udvises forsigtighed og hyppigt udføres monitorering af serumkalium, hvis en sådan samtidig behandling er nødvendig på grund af dokumenteret hypokaliæmi.
English: Kinzalmono 40 mg tablets EU/1/98/091/001 (14 tablets) EU/1/98/091/002 (28 tablets) EU/1/98/091/003 (56 tablets) EU/1/98/091/004 (98 tablets) EU/1/98/091/013 (28 x 1 tablets)
Danish: Kinzalmono 40 mg tabletter EU/1/98/091/001 (14 tabletter) EU/1/98/091/002 (28 tabletter) EU/1/98/091/003 (56 tabletter) EU/1/98/091/004 (98 tabletter) EU/1/98/091/013 (28 x 1 tabletter)
English: Kinzalmono 80 mg tablets White oblong tablets of 4.6 mm engraved with the code number '52H' on one side.
Danish: Kinzalmono 80 mg tabletter er hvide aflange tabletter, hvorpå koden 52H er præget.
English: Kinzalmono 20 mg tablets Pack sizes: Blister with 14, 28, 56 or 98 tablets.
Danish: Pakningsstørrelser: Blister med 14, 28, 56 eller 98 tabletter.
English: Kinzalmono 80 mg tablets EU/1/98/091/005 (14 tablets) EU/1/98/091/006 (28 tablets) EU/1/98/091/007 (56 tablets) EU/1/98/091/008 (98 tablets) EU/1/98/091/014 (28 x 1 tablets)
Danish: Kinzalmono 80 mg tabletter EU/1/98/091/005 (14 tabletter) EU/1/98/091/006 (28 tabletter) EU/1/98/091/007 (56 tabletter) EU/1/98/091/008 (98 tabletter) EU/1/98/091/014 (28 x 1 tabletter)
English: Prior treatment with high dose diuretics such as furosemide (loop diuretic) and hydrochlorothiazide (thiazide diuretic) may result in volume depletion and in a risk of hypotension when initiating therapy with telmisartan.
Danish: Der kan opstå volumendepletion og risiko for hypotension ved initiering af behandling med telmisartan, hvis patienten forudgående har modtaget behandling med høje doser af diuretika såsom furosemid (loop-diuretika) og hydrochlorthiazid (thiazid-diuretika),
English: Kinzalmono 40 mg tablets White oblong tablets of 3.8 mm engraved with the code number '51H' on one side.
Danish: Hvide aflange 3,8 mm tabletter, hvori koden 51H er præget.
English: NAME OF THE MEDICINAL PRODUCT Kinzalmono 80 mg tablets telmisartan
Danish: LÆGEMIDLETS NAVN Kinzalmono 80 mg tabletter Telmisartan
English: Telmisartan was found to be similarly effective to ramipril in the pre-specified secondary endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.99 (97.5 % CI 0.901.08), p (non-inferiority) = 0.0004], the primary endpoint in the reference study HOPE (The Heart Outcomes Prevention Evaluation Study), which had investigated the effect of ramipril vs. placebo.
Danish: Mht. det prædefinerede sekundære endepunkt (reduktion af kardiovaskulær død, ikke-letalt myokardieinfarkt og ikke-letal apopleksi) - som var identisk med det primære endepunkt i HOPEstudiet (The Heart Outcomes Prevention Evaluation Study) - blev telmisartan fundet ligeværdig med ramipril [0,99 (97,5% CI 0,90-1,08, p (non-inferioritet) = 0,0004)].
English: NAME OF THE MEDICINAL PRODUCT Kinzalmono 20 mg tablets telmisartan
Danish: LÆGEMIDLETS NAVN Kinzalmono 20 mg tabletter Telmisartan
English: Because no information is available regarding the use of Kinzalmono during breast-feeding, Kinzalmono is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Danish: Som alternativ anbefales behandlingsregimer med bedre etablerede sikkerhedsprofiler ved amning, specielt ved amning af nyfødte og præmature spædbørn.
English: The risk may increase in case of treatment combination with other medicinal products that may also provoke hyperkalaemia (salt substitutes containing potassium, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non-steroidal antiinflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim).
Danish: Lægemidler, der kan udløse hyperkaliæmi: Kaliumholdige saltsubstitutter, kaliumbesparende diuretika, ACE-hæmmere, angiotensin II-receptorantagonister, non steroide antiinflammatoriske lægemidler (NSAIDs herunder selektive COX-2-hæmmere), heparin, immunsuppressiva (ciclosporin eller tacrolimus) og trimethoprim.
English: Kinzalmono 40 mg and 80 mg tablets Pack sizes: Blister with 14, 28, 56 or 98 tablets or perforated unit dose blisters with 28 x 1 tablets.
Danish: Pakningsstørrelser: Blister med 14, 28, 56 eller 98 tabletter eller perforeret enkeltdosis-blister med 28 x 1 tabletter.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med Kinzalmono Fortæl altid lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for nylig.
English: What Kinzalmono looks like and contents of the pack Kinzalmono 40 mg tablets are white, oblong-shaped and engraved with the code number '51H' on one side.
Danish: Kinzalmono 40 mg tabletter er hvide aflange tabletter, hvorpå koden 51H er præget.
English: NAME OF THE MEDICINAL PRODUCT Kinzalmono 20 mg tablets
Danish: LÆGEMIDLETS NAVN Kinzalmono 20 mg tabletter Kinzalmono 40 mg tabletter Kinzalmono 80 mg tabletter
English: Low blood pressure (hypotension) in users treated for reduction of cardiovascular events.
Danish: Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 brugere): Lavt blodtryk (hypotension) hos patienter, der er i behandling for at nedsætte risikoen for hjerte-karhændelser.
English: This treatment course is repeated one year later.
Danish: Dette behandlingsforløb gentages et år senere.
English: No other medicines should be taken within 3 hours of a Mavenclad tablet.
Danish: Ingen andre lægemidler bør indtages inden for 3 timer fra indtagelse af en Mavenclad-tablet.
English: The first year, patients take one to two tablets a day for 4 or 5 days; after one month, they again take one to two tablets a day for 4 or 5 days, adding up to a total dose of 1.75 mg per kg body weight over the two periods.
Danish: Det første år skal patienten tage en til to tabletter pr. dag i 4 eller 5 dage; efter en måned skal patienten igen tage en til to tabletter pr. dag i 4 eller 5 dage, hvilket giver en dosis på sammenlagt 1,75 mg pr. kg kropsvægt over de to perioder.
English: The full EPAR for Mavenclad can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Mavenclad findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Mavenclad.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Mavenclad.
English: The dose depends on patients' body weight and treatment consists of two courses spread over 2 years.
Danish: Dosis afhænger af patientens kropsvægt, og behandlingen består af to forløb, der er fordelt over 2 år.
English: It must not be given to patients with active cancers.
Danish: Det må ikke gives til patienter med kræft i udbrud.
English: Mavenclad is used in patients whose disease is highly active.
Danish: Mavenclad anvendes til patienter, hvis sygdom er meget aktiv.
English: Mavenclad cladribine
Danish: Mavenclad cladribin
English: In a follow-up study for up to a further 2 years, benefit of the original treatment was maintained but there seemed no additional benefit from giving more than 2 courses of Mavenclad treatment.
Danish: I et opfølgningsstudie, der varede i yderligere 2 år, blev fordelene ved den oprindelige behandling opretholdt, men der var ikke tegn på yderligere fordele ved at give mere end 2 behandlingsforløb med Mavenclad.
English: The European Medicines Agency therefore decided that Mavenclad's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede derfor, at fordelene ved Mavenclad opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The immune cells called lymphocytes play a key role in this process.
Danish: De immunokompetente celler, også kaldet lymfocytter, spiller en nøglerolle i denne proces.
English: Cladribine is already approved in the EU for the treatment of certain leukaemias (cancers affecting lymphocytes).
Danish: Cladribin er allerede blevet godkendt i EU til behandling af visse former for leukæmi (kræftformer, der påvirker lymfocytterne).
English: Treatment must also be avoided in patients whose kidney function is moderately or severely reduced, and in women who are pregnant or breast feeding.
Danish: Behandling skal også undgås hos patienter, hvis nyrefunktion er moderat til alvorligt svækket, og i gravide eller ammende kvinder.
English: Rashes, hair loss and lowered counts of another type of white blood cell, neutrophils, may also affect up to 1 patient in 10.
Danish: Hududslæt, hårtab og nedsatte tal for en anden type hvide blodceller, neutrofiler, kan også påvirke op til 1 ud af 10 patienter.
English: It contains the active substance cladribine.
Danish: Det indeholder det aktive stof cladribin.
English: This appeared to be most marked in patients with highly active disease, in whom the clinical benefits were considered to outweigh the risks of a severe long-term lowering in lymphocyte numbers, which increases the risk of infection and possibly of cancer.
Danish: Dette viste sig at være mest markant hos patienter med meget aktiv sygdom, hvor de kliniske fordele blev betragtet som værende i stand til at opveje risikoen for en alvorlig langsigtet nedsættelse af lymfocyttallene, der kan øge risikoen for infektion og muligvis for kræft.
English: The study compared the effect of Mavenclad and placebo (a dummy treatment) in reducing the relapse rate 96 weeks after the start of treatment.
Danish: Forsøget sammenlignede virkningen af Mavenclad og placebo (en uvirksom behandling) til nedsættelse af den recidiverende hyppighed 96 uger efter behandlingens start.
English: Other information about Mavenclad
Danish: Andre oplysninger om Mavenclad
English: In addition, the fact that Mavenclad is given by mouth, and requires only 2 short courses 12 months apart, offers an advantage to patients.
Danish: I tillæg hertil er det faktum, at Mavenclad gives i tabletform og kun kræver 2 korte behandlingsforløb med 12 måneders mellemrum, en stor fordel for patienterne.
English: What measures are being taken to ensure the safe and effective use of Mavenclad?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Mavenclad?
English: The company that markets Mavenclad will provide information on the medicine for healthcare professionals and patients, including advice on the side effects and safety concerns, the need for monitoring before and during treatment, and on pregnancy prevention and effective contraception in both female and male patients.
Danish: Virksomheden, der markedsfører Mavenclad, vil give oplysninger om lægemidlet til sundhedspersonale og patienter, deriblandt rådgivning vedrørende bivirkninger og sikkerhedsforanstaltninger, monitoreringsbehov før og under behandlingen og om forebyggelse af graviditet og effektiv antikonception hos både kvindelige og mandlige patienter.
English: The results suggested that the effects were greatest in patients with highly active disease and that benefit might be expected in other relapsing forms of multiple sclerosis.
Danish: Resultaterne antydede, at virkningen var størst hos patienter med en meget aktiv sygdom, og at der kunne forventes fordele for patienter med andre former for recidiverende multipel sklerose.
English: In addition, patients given Mavenclad were nearly 50% less likely to have disease progression (indicated as an increase in disability that lasted for at least 6 months).
Danish: I tillæg hertil havde patienter, der fik Mavenclad, næsten 50 % mindre tendens til at have sygdomsprogression (angivet som en nedsættelse af funktionsevnen, der varede i mindst 6 måneder).
English: The active substance in Mavenclad, cladribine, has a similar chemical structure to purine, one of the substances needed to make up the DNA.
Danish: Det aktive stof i Mavenclad, cladribin, har en molekylstruktur, der ligner purin, et af de stoffer, der er nødvendige til dannelse af DNA.
English: Effects on lymphocytes reduce the body's immune defence against infections and cancer: Mavenclad must not be given to patients with active long-term infections such as tuberculosis or hepatitis, nor to patients with HIV infection or whose immune defences are weakened for other reasons such as treatment with medicines that suppress the immune system.
Danish: Påvirkningen af kroppens lymfocytter vil nedsætte dens immunforsvarssystem mod infektion og kræft: Mavenclad må ikke ordineres til patienter med aktive langtidsinfektioner såsom tuberkulose eller hepatitis, ej heller til patienter med HIV-infektion eller hvis immunforsvar er svækket af andre årsager, som f.eks. behandling med lægemidler, der undertrykker immunsystemet.
English: In multiple sclerosis, the body's immune (defence) system attacks and damages the protective sheath around the nerve cells in the central nervous system (the brain and spinal cord).
Danish: Ved multipel sklerose angriber og beskadiger kroppens immun(forsvars)system den beskyttende skede omkring nervecellerne i centralnervesystemet (hjernen og rygmarven).
English: Mavenclad can only be obtained with a prescription and treatment must be started and supervised by a doctor experienced in treating multiple sclerosis.
Danish: Mavenclad udleveres kun efter recept, og behandlingen skal påbegyndes og overvåges af en læge med erfaring i behandling af multipel sklerose.
English: The most common side effects with Mavenclad are lymphopenia (reduction in lymphocytes, which may affect more than 1 in 10 people) and infections with herpes zoster virus, in up to 1 patient in 10.
Danish: De hyppigste bivirkninger ved Mavenclad er lymfopeni (reducering af lymfocyttallet, der kan påvirke mere end 1 ud af 10 patienter) og infektioner med herpes zoster-virus i op til 1 ud af 10 patienter.